TotalMarketCap

CollPlant Biotechnologies

CLGNNasdaq IsraelHealth CareIndustrial Specialties

Market cap

$12.364 M

$4.02 -4.96%

Close of 6 Nov 2026

As of 6 Nov 2026, CollPlant Biotechnologies (CLGN) has a market capitalization of $12.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.37M

#3373 by revenue

Earnings

-$11.5M

Loss-making

Shares outstanding

12,803,006

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Industrial Specialties, ranked by market cap

All 55 →
  1. #51Cuprina Holdings (Cayman)CUPR$13.5M
  2. #52HeartSciencesHSCS$12.8M
  3. #53CollPlant BiotechnologiesCLGN$12.4M
  4. #54Regentis BiomaterialsRGNT$8.43M
  5. #55Bone BiologicsBBLG$1.09M

What if CollPlant Biotechnologies were worth as much as…

Open the what-if tool →

Gold $28.2T

$9,181,048

Per share 2,283,843× higher

Bitcoin $1.53T

$496,770.54

Per share 123,575× higher

Apple $5.02T

$1,630,851

Per share 405,684× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for CollPlant Biotechnologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.